| 1 |
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
Mathias Rummel, N. Niederle, Georg Maschmeyer et al. · The Lancet
|
19 Feb 2013 |
1,515 |
| 2 |
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
Christoph Röllig et al. · The Lancet Oncology
Open access |
5 Nov 2015 |
404 |
| 3 |
Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process
Cathy Bennett et al. · Gastroenterology
Open access |
24 Apr 2012 |
378 |
| 4 |
Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial
Karl Heinrich Scholz, Sebastian K.G. Maier, Lars Siegfried Maier et al. · European Heart Journal
Open access |
18 Jan 2018 |
377 |
| 5 |
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
Volkmar Boehme, Samira Zeynalova, Marita Kloess et al. · Annals of Oncology
Open access |
4 Oct 2006 |
280 |
| 6 |
Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats
FRIEDRICH POTT, U Ziem, Franz Josef Reiffer et al. · Experimental Pathology
|
1987 |
268 |
| 7 |
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV
Susanne Saußele et al. · Blood
Open access |
27 Apr 2015 |
205 |
| 8 |
Personality characteristics and behaviour problems in individuals of different ages with Williams syndrome
Angela Gosch, Rainer Pankau · Developmental Medicine & Child Neurology
|
Aug 1997 |
185 |
| 9 |
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
Franziska Taube et al. · Blood
Open access |
28 Jul 2021 |
174 |
| 10 |
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma
C. Manegold, James Thomas Symanowski, Ulrich Gatzemeier et al. · Annals of Oncology
Open access |
12 Apr 2005 |
162 |
| 11 |
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial
Mathias Rummel, Ulrich Kaiser, Christina Balser et al. · The Lancet Oncology
|
4 Dec 2015 |
155 |
| 12 |
Diverticular Disease: Guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases and the German Society for General and Visceral Surgery
Wolfgang Kruis, Christoph‐Thomas Germer, Ludger Leifeld · Digestion
|
2014 |
148 |
| 13 |
S2k-Leitlinie Divertikelkrankheit/Divertikulitis
L. Leifeld, C. T. Germer, S. Böhm et al. · Zeitschrift für Gastroenterologie
Open access |
15 Jul 2014 |
145 |
| 14 |
Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial
Giorgio V. Scagliotti, C. Kortsik, Graham G. Dark et al. · Clinical Cancer Research
Open access |
15 Jan 2005 |
138 |
| 15 |
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Christoph Röllig et al. · Blood
Open access |
4 Jun 2020 |
137 |
| 16 |
Peritoneal metastasis in gastric cancer: results from the German database
for the Peritoneum Surface Oncology Group and members of the StuDoQ|Peritoneum R, Beate Rau, Andreas Brandl et al. · Gastric Cancer
Open access |
21 Jun 2019 |
133 |
| 17 |
Evidence for Genetic Regulation of Susceptibility to Toxoplasmic Encephalitis in AIDS Patients
Yasuhiro Suzuki, Sin-Yew Wong, F. Carl Grumet et al. · The Journal of Infectious Diseases
Open access |
1996 |
126 |
| 18 |
PIK3CA-mutations in breast cancer
Kristin Reinhardt, Kathrin Stückrath, Carolin Hartung et al. · Breast Cancer Research and Treatment
Open access |
24 Oct 2022 |
118 |
| 19 |
The Efficacy and Safety of BI 2536, a Novel Plk-1 Inhibitor, in Patients with Stage IIIB/IV Non-small Cell Lung Cancer Who Had Relapsed after, or Failed, Chemotherapy: Results from an Open-Label, Randomized Phase II Clinical Trial
Martin Sebastian, Martin Reck, Cornelius Florian Waller et al. · Journal of Thoracic Oncology
Open access |
4 Jun 2010 |
116 |
| 20 |
Sequential Nephron Blockade Breaks Resistance to Diuretics in Edematous States
Heinrich Knauf, E. Mutschler · Journal of Cardiovascular Pharmacology
|
Mar 1997 |
106 |
| 21 |
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
Stephan Bernhardt, Michaela Bayerlová, Martina Vetter et al. · Breast Cancer Research
Open access |
11 Oct 2017 |
105 |
| 22 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group
Norbert Schmitz, Samira Zeynalova, B. Glaß et al. · Annals of Oncology
Open access |
12 Oct 2011 |
105 |
| 23 |
Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy
Steffen Syrbe et al. · Brain
Open access |
19 Jul 2017 |
103 |
| 24 |
One hundred and one over-the-scope-clip applications for severe gastrointestinal bleeding, leaks and fistulas
Edris Wedi · World Journal of Gastroenterology
Open access |
2016 |
103 |
| 25 |
Transgastric surgery in the abdomen: the dawn of a new era?
Juergen H. Hochberger, Wolfram Lamadé · Gastrointestinal Endoscopy
|
26 Jul 2005 |
103 |
| 26 |
Clinical Pharmacokinetics and Pharmacodynamics of Torasemide
Heinrich Knauf, E. Mutschler · Clinical Pharmacokinetics
|
1998 |
101 |
| 27 |
Diuretic Effectiveness of Hydrochlorothiazide and Furosemide Alone and in Combination in Chronic Renal Failure
Heinrich Knauf, E. Mutschler · Journal of Cardiovascular Pharmacology
|
Sep 1995 |
98 |
| 28 |
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison
Wolfgang Kern, Carlo Aul, Georg Maschmeyer et al. · Leukemia
|
Jul 1998 |
95 |
| 29 |
Long-term follow-up after successful interferon therapy of acute hepatitis C
Johannes Wiegand, Elmar Jäckel, Markus Cornberg et al. · Hepatology
|
Jul 2004 |
94 |
| 30 |
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Rüdiger Hehlmann et al. · Leukemia
Open access254 authors |
7 May 2020 |
93 |
| 31 |
Characterization of glycosylphosphatidylinositol biosynthesis defects by clinical features, flow cytometry, and automated image analysis
Alexej Knaus et al. · Genome Medicine
Open access |
5 Jan 2018 |
89 |
| 32 |
Measurement in Vivo of the Survival Rate in Autologous Adipocyte Transplantation
Bernd Rieck, Sabine Schlaak · Plastic & Reconstructive Surgery
|
Jun 2003 |
89 |
| 33 |
A non-destructive method for the morphological assessment of earthworm burrow systems in three dimensions by X-ray computed tomography
Monika Joschko, Otto Graff, P. C. M�ller et al. · Biology and Fertility of Soils
|
May 1991 |
89 |
| 34 |
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial
on behalf of the German CUP Study Group, Gerdt Huebner, Hartmut Link et al. · British Journal of Cancer
Open access |
9 Dec 2008 |
87 |
| 35 |
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma – Results of a comprehensive meta-analysis
Alexander Greb, Julia Bohlius, Sven Trelle et al. · Cancer Treatment Reviews
|
3 Apr 2007 |
86 |
| 36 |
Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial
A Tikidzhieva, Axel Benner, Sara Michel et al. · British Journal of Cancer
Open access |
21 Feb 2012 |
80 |
| 37 |
Probiotics Regulate the Expression of COX-2 in Intestinal Epithelial Cells
Jan‐Michel Otte, Rudja Mahjurian-Namari, Stephan Brand et al. · Nutrition and Cancer
|
30 Dec 2008 |
75 |
| 38 |
Impact of COVID-19 outbreak on regional STEMI care in Germany
Karl Heinrich Scholz, Björn Daniel Lengenfelder, Christian Thilo et al. · Clinical Research in Cardiology
Open access |
16 Jul 2020 |
73 |
| 39 |
Longitudinal evaluation of growth, puberty, and bone maturation in children with Williams syndrome
Carl‐Joachim Partsch, Gunther Dreyer, Angela Gosch et al. · The Journal of Pediatrics
|
1999 |
73 |
| 40 |
Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database
Arne Simon, Roland A. Ammann, Anja Wilkesmann et al. · European Journal of Pediatrics
Open access |
15 Feb 2007 |
71 |
| 41 |
Interleukin 17, Produced by γδ T Cells, Contributes to Hepatic Inflammation in a Mouse Model of Biliary Atresia and Is Increased in Livers of Patients
Christian Klemann, Arne Schröder, Anika Dreier et al. · Gastroenterology
Open access |
25 Sep 2015 |
70 |
| 42 |
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
Jan‐Niklas Eckardt et al. · Journal of Hematology & Oncology
Open access |
13 May 2022 |
68 |
| 43 |
De novo 13q deletions in two patients with mild anorectal malformations as part of VATER/VACTERL and VATER/VACTERL‐like association and analysis of EFNB2 in patients with anorectal malformations
Gabriel C. Dworschak et al. · American Journal of Medical Genetics Part A
|
16 Aug 2013 |
66 |
| 44 |
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
Christina Rautenberg et al. · Blood Cancer Journal
Open access |
4 Oct 2021 |
65 |
| 45 |
Contact-to-Balloon Time and Door-to-Balloon Time After Initiation of a Formalized Data Feedback in Patients With Acute ST-Elevation Myocardial Infarction
Karl Heinrich Scholz, Reinhard Hilgers, Dorothe Ahlersmann et al. · The American Journal of Cardiology
|
27 Nov 2007 |
62 |
| 46 |
Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Ulrich Mey, Katjana S. Orlopp, Dimitri Flieger et al. · Cancer Investigation
|
2006 |
61 |
| 47 |
Adult patients with Prader-Willi syndrome: Clinical characteristics, life circumstances and growth hormone secretion
CJ Partsch, Constanze Lämmer, Gabriele Gillessen‐Kaesbach et al. · Growth Hormone & IGF Research
|
Apr 2000 |
61 |
| 48 |
Value of Chromoendoscopy and Magnification Endoscopy in the Evaluation of Duodenal Abnormalities: a Prospective, Randomized Comparison
Ralf Kießlich, Klaus Mergener, Christopher R. Naumann et al. · Endoscopy
|
24 Jun 2003 |
60 |
| 49 |
Current Guidelines for the Treatment of Severe Pneumonia and Sepsis
K.‐F. Bodmann · Chemotherapy
|
2005 |
60 |
| 50 |
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial
Christoph Röllig et al. · Leukemia
Open access |
18 Feb 2021 |
59 |